CHEBI:63616 - pemetrexed

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name pemetrexed
Definition An N-acylglutamic acid in which the N-acyl group is specified as 4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl. Inhibits thymidylate synthase (TS), 421 dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT).
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Anonymous
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C20H21N5O6
Net Charge 0
Average Mass 427.41060
Monoisotopic Mass 427.14918
InChI InChI=1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1
SMILES Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1
Roles Classification
Chemical Role(s): Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): antimetabolite
A substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
EC (thymidylate synthase) inhibitor
An EC 2.1.1.* (methyltransferases) inhibitor that interferes with the action of thymidylate synthase (EC
EC (dihydrofolate reductase) inhibitor
An EC 1.5.1.* (oxidoreductase acting on donor CH-NH group, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of dihydrofolate reductase (EC
EC (phosphoribosylglycinamide formyltransferase) inhibitor
An EC 2.1.2.* (hydroxymethyl-, formyl- and related transferases) inhibitor that interferes with the action of phosphoribosylglycinamide formyltransferase (EC
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing pemetrexed (CHEBI:63616) has role antimetabolite (CHEBI:35221)
pemetrexed (CHEBI:63616) has role antineoplastic agent (CHEBI:35610)
pemetrexed (CHEBI:63616) has role EC (dihydrofolate reductase) inhibitor (CHEBI:50683)
pemetrexed (CHEBI:63616) has role EC (thymidylate synthase) inhibitor (CHEBI:63720)
pemetrexed (CHEBI:63616) has role EC (phosphoribosylglycinamide formyltransferase) inhibitor (CHEBI:63721)
pemetrexed (CHEBI:63616) is a N-acyl-L-glutamic acid (CHEBI:21650)
pemetrexed (CHEBI:63616) is a pyrrolopyrimidine (CHEBI:38670)
pemetrexed (CHEBI:63616) is conjugate acid of pemetrexed(2−) (CHEBI:63724)
Incoming pemetrexed(2−) (CHEBI:63724) is conjugate base of pemetrexed (CHEBI:63616)
N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-L-glutamic acid
INN Source
pemetrexed KEGG DRUG
Manual Xrefs Databases
DB00642 DrugBank
EP432677 Patent
Pemetrexed Wikipedia
US5344932 Patent
View more database links
Registry Numbers Types Sources
137281-23-3 CAS Registry Number ChemIDplus
137281-23-3 CAS Registry Number KEGG DRUG
9097855 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
21129871 PubMed citation Europe PMC
21831719 PubMed citation Europe PMC
21900836 PubMed citation Europe PMC
21937141 PubMed citation Europe PMC
22021325 PubMed citation Europe PMC
22116317 PubMed citation Europe PMC
22124474 PubMed citation Europe PMC
22134068 PubMed citation Europe PMC
22201521 PubMed citation Europe PMC
22223137 PubMed citation Europe PMC
22237209 PubMed citation Europe PMC
22240216 PubMed citation Europe PMC
22243773 PubMed citation Europe PMC
22244076 PubMed citation Europe PMC
22258853 PubMed citation Europe PMC
Last Modified
25 February 2016